Screening businesses acquired by SkinCity
SkinCity, the Wiltshire-based supplier of aromotherapy products, has acquired Leeds Ultrasound Screening Service (LUSS) and Genome, the companies which jointly run the Leeds Screening Centre. The acquisition forms part of SkinCity’s growth strategy to build a personal products lifestyle group.
The founders of LUSS and Genome, Gerald Mason and Professor Howard Cuckle respectively, will retain a stake in the business, which provides fetal ultrasound screening services. Mason and Cuckle will be acting as consultants to Genome Screening in the future.
SkinCity chief executive, Ian Richardson, said: “I am delighted to be working with Gerald and Howard. Their work at the Leeds Screening Centre has placed it at the forefront of scanning and screening services, offering what we believe to be an unparalleled range of services and tests for not only genetic conditions such as Down's Syndrome, but also pre-eclampsia.
"Genetic screening in conjunction with ultrasound scanning has the potential to enable expectant parents to know more about their baby before birth than ever before. We share the same vision of providing these services to parents from a network of centres nationwide. This is the latest addition to SkinCity and its overall plan to create a group covering all aspects of individuals' health and wellbeing."
